Abstract:
PROCESS FOR THE PREPARATION OF RACEMIC OR OPTICALLYACTIVE CEPHALOSPORINE DERIVATIVES OF THE FORMULA
2,3-(-CO-N(-R1)-CH2-),7-NH2-2-CEPHEM
WHEREIN R1 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, ALKYL, SUBSTITUTED AKYL, ARYL AND SUBSTITUTED ARYL, WHICH COMPRISES THE STEPS OF REACTING AN AMINO ACID OF THE FORMULA
R1-NH-CH2-CH2-COOH
WITH BENZYL ALCOHOL, CONDENSING THE BENZYL ESTER THUS OBTAINED WITH AN OXALATE, CONVERTING THE BENZYL ESTER OF 2,3DIOXI-4-CARBOXY-PYRROLIDINE INTO THE CORRESPONDING ACID, SUBJECTING SAID ACID TO AMINOMETHYLATION, THUS YIELDING A COMPOUND OF THE FORMULA
1-R1,3-OH,4-(R"-N(-R'')-CH2-)PYRROL-3-IN-2-ONE
CONVERTING SAID COMPOUND INTO THE CORRESPONDING 4-ACYLTHIOMETHYL DERIVATIVE, CONVERTING SAID DERIVATIVE INTO THE CORRESPONDING 4-THIOMETHYL DERIVATIVE, CONDENSING SAID DERIVATIVE WITH AN ENAMINE OF THE FORMULA
SUBJECTING SAID COMPOUND TO THE ACTION OF A TRITYLATION AGENT, RECOVERING THE THREO ISOMER OF THE TRITYLATED DERIVATIVE, LACTAMIZING SAID THREO ISOMER TO OBTAIN THE Y-LACTAM OF DL-6H,7H-CIS-7-TRITYLAMINO-3-AMINOALKYL-CEPH 3-EME-4-CARBOXYLIC ACID, DETRITYLATING SAID Y-LACTAM AND RECOVERING SAID RACEMIC OF OPTICALLY ACTIVE CEPHALOSPORIN DERIVATIVES. THESE COMPOUNDS ARE USEFUL AS INTERMEDIATES IN THE PREPARATION OF THE CORRESPONDING 7ACYLAMINO DERIVATIVES OF THE FORMULA
2,3-(-CO-N(-R1)-CH2-),7-(R2-NH-)-2-CEPHEM
WHEREIN R1 HAS THE ABOVE DEFINITION AND R2 IS THE ACYL OF AN ORGANIC CARBOXYLIC ACID WHICH COMPOUNDS ARE ALSO PART OF THE INVENTION AND ARE USEFUL AS ANTIBIOTICS.
Abstract:
Novel 3,3-dimethyl-2-(2''-oxo-3''-x-cyclopentylidenemethyl)-1cyclopropanecarboxylic acids of a cis or trans structure, in the form of racemic mixtures or optically active isomers of the formula
WHEREIN X is selected from the group consisting of oxygen, sulfur and imino and R is selected from the group consisting of hydrogen, lower alkyl of one to six carbons, a radical of the formula
WHEREIN Y3 is aryl such as phenyl, and a radical of the formula
WHEREIN Z is alkenyl or alkadienyl such as allyl, butenyl and pentadienyl and their preparation and intermediates therefor.
Abstract translation:具有下式的外消旋混合物或光学活性异构体的顺式或反式结构的新的3,3-二甲基-2-(2'-氧代-3'-x-环戊基亚甲基)-1-环丙烷甲酸为式WHEREIN X 选自氧,硫和亚氨基,R选自氢,1至6个碳的低级烷基,式WHEREIN Y 3为芳基如苯基的基团和式 其中Z是烯基或链二烯基,例如烯丙基,丁烯基和戊二烯基及其制备方法和中间体。
Abstract:
Aryl allyl sulfones of the formula WHEREIN Ar is phenyl optionally substituted with lower alkyl, lower alkoxy, halomethyl, nitro or halogen and HA has the formula WHEREIN R''1 is hydrogen or lower alkyl and FORM FLUORENE OR SATURATED OR UNSATURATED CYCLOALKYL OF THREE TO SEVEN CARBON ATOMS OPTIONALLY SUBSTITUTED WITH ONE OR MORE LOWER ALKYL AND/OR LOWER ALKOXY USEFUL AS INTERMEDIATES IN THE PREPARATION OF CYCLOPROPANECARBOXYLIC ACID ESTERS HAVING INSECTICIDAL ACTIVITY.
WHEREIN ALK IS ALKYL OF 1 TO 7 CARBON ATOMS, R IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS AND A-TETRAHYDROPYRANYL AND M IS 3, 4 OR 5 WHICH ARE INTERMEDIATES FOR PROSTAGLANDINS AND THEIR PREPARATION AND NOVEL INTERMEDIATES.
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
Abstract:
WHEREIN THE CO2H substituent on the carbon 1 and the
Process for the preparation of an internal hemiacylal of racemic or optically active cis 3,3-dimethyl-2-formyl-cyclopropane-1carboxylic acid which are intermediates for the preparation of racemic or optically-active cyclopropane carboxylic acid of the formula SUBSTITUENT ON THE CARBON 2 ARE IN THE CIS-POSITION RELATIVE TO ONE ANOTHER, R1 represents a hydrogen, an alkyl radical, an aralkyl radical, an aryl radical, an alkenyl radical, an alkynyl radical, a cycloalkyl radical, a cycloalkenyl radical, a heterocyclic radical, these radicals being able to be substituted, specifically by lower alkyl or lower alkoxy, or represents a cyano group, an acyl group, a formyl group, an alkoxy-carbonyl group or a nitro group, and Z represents the R2 residue which has the same meaning as R1 but is identical or different thereto, or the R3 residue, which represents an allyl radical, a benzyl radical, a cyano group, an acyl group, a formyl group, an alkoxycarbonyl group, or a nitro group, or R1 and Z together form a saturated or unsaturated carbon homocycle or heterocycle, whose ring can support substituents such as lower alkyls or lower alkoxys, or functions such as ketonic functions, or together form a polycyclic aromatic residue such as a fluorene residue.
Abstract:
1. AN INSECTIDAL COMPOSITION COMPRISING AN INSECTICIDALLY EFFECTIVE AMOUNT OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OFF OPTICALLY ACTIVE AND RACEMIC MIXTURES OF A COMPOUND OF THE FORMULA
WHEREIN X IS SELECTED FROM THE GROUP CONSISTING OF OXYGEN AND SULFUR AND R IS SELECTED FROM THE GROUP CONSISTING OF ALKYL OF 1 TO 6 CARBON ATOMS, A RADICAL OF THE FORMULA
-CH2-(FURYLENE)-CH2-Y3
WHEREIN Y3 IS PHENYL, AND A RADICAL OF THE FORMULA WHEREIN Z IS SELECTED FROM THE GROUP CONSISTING OF ALKENYL OF 2 TO 7 CARBON ATOMS AND ALKADIENYL OF 4 TO 7 CARBON ATOMS; AND AN INERT CARRIER.
Abstract:
A PROCESS FOR THE PREPARATION OF RACEMIC CIS CHRYSANTHEMIC ACID OR OF THE (1R,2S) CONFIGURATION OR OF THE (1S,2R) CONFIGURATION BEGINNING RESPECTIVELY FROM RACEMIC TRANS 3,3-DIMETHYL-2-(2''-HYDROXY-2''-METHYLPROPYL)-CYCLOPROPANEL-CARBOXYLIC ACID OR OF THE (1S,2S) CONFIGURATION OR OF THE (1R,2R) CONFIGURATION.
IT IS KNOWN THAT EBURANAMONINE HAS BEEN ISOLATED FROM SEVERAL PLANT SPECIES SUCH AS VINCA MINOR AND HUNTERIA EBURNEA. EBURNAMONINE POSSESSES INTERESTING PHARMACOLOGICAL PROPERIES, IT PROVOKES A HYPERTENSION ACCOMPANIED BY A RESPIRATORY AND CARDIAC STIMULATION AND AN INCREASE OF TONICITY. IN ADDITION, EBURNAMONINE CAN SERVE AS STARTING MATERIAL IN THE SYNTHESIS OF KNOWN ANALOGOUS COMPOUNDS DISPLAYING AN INTERESTING PHYSIOLOGICAL ACTIVITY.